Comparison of bone and 2-Deoxy-2-[18F]fluoro-d-glucose positron emission tomography in the evaluation of bony metastases in lung cancer

Molecular Imaging and Biology

Volumn 5, Issue 1, 2003, Pages 26-31

  Gayed, Isis ^a   Vu, Thuan ^a   Johnson, Marcella ^a   Macapinlac, Homer ^a   Podoloff, Donald ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Bone scans; Bony metastases; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BONE LESION; BONE METASTASIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HUMAN; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RIB; SENSITIVITY AND SPECIFICITY; THORAX WALL;

AGED; BONE NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0038584863     PISSN: 15361632     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1536-1632(03)00036-2     Document Type: Article

References (28)

1. Cook G. Fogelman I. The role of positron emission tomography in the management of bone metastases Cancer 88 suppl 2000 2927-2933
2. 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography J Clin Oncol 20 2002 379-387
3. Cook G. Fogelman I. Detection of bone metastases in cancer patients by 18F-fluoride and 18F-fluorodeoxyglucose positron emission tomography Q J Nucl Med 45 2001 47-52
4. Maisey M. Wahl R. Barrington S. Atlas of clinical positron emission tomography 1999 Oxford University Press New York
5. Engel H. Steinerm H. Buck A. et al. Whole body PET: physiologic and artifactual flourodeoxyglucode accumulations J Nucl Med 37 1996 441-446
6. Hoh C. Schiepers C. Seltzer M. et al. PET in oncology: will it replace the other modalities? Semin Nucl Med 27 1997 94-106
7. Cheon G. Chung J.-K. Kim J. et al. Diagnostic usefulness of F18 FDG whole body PET in the detection of bony metastasis compared to Tc-99m MDP bone scan J Nucl Med 40 1999 96P
8. Heges L. Olkin I. Statistical methods for meta-analysis 1985 Academic Press San Diego, CA
9. Yeh S. Imbriaco M. Larson S. et al. Detection of bony metastases of androgen-independent prostate cancer by PET-FDG Nucl Med Biol 23 1996 693-697
10. Moon D. Maddahi J. Silverman D. et al. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma J Nucl Med 39 1998 431-435
11. Wahl R. Cody R. Hutchins G. Mudgett E. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose Radiology 179 1991 765-770
12. Moog F. Kotzerke J. Reske S. FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma J Nucl Med 40 1999 1407-1413
13. Durski J. Sirnivas S. Segall G. Comparison of FDG-PET and bone scans for detecting skeletal metastases in patients with non-small cell lung cancer Clin Pos Imag 3 2000 97-105
14. Daldrap-Link H. Franzius C. Link T. et al. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET Am J Roentgenol 177 2001 229-236
15. Hung G. Tan T. Kao C. Wang S. Multiple skeletal metastases of Ewing's sarcoma demonstrated on FDG-PET and compared with bone and gallium scans Gaoxiong Yi Xue Ke Xue Za Zhi 156 2000 315 -318
16. Franzius C. Sciuk J. Daldrup-Link H. Jurgens H. Schober O. FDG-PET for detection of osseous metastases from malignant primary bone tumors: comparison with bone scintigraphy Eur J Nucl Med 27 2000 1305-1311
17. Weber W. Schmidt R. Bruchhaus H. Hillinger S. Von Schulthess G. Steiner H. Detection of extrathoeacic metastases by positron emission tomography in lung cancer Lancet 344 1994 1265-1266
18. Marom E. McAdams H. Erasmus J. Staging non-small cell lung cancer with whole body PET Radiology 212 1999 803-809
19. Bury T. Dowalti A. Paulus P. Hustinx R. Radermacker M. Rigo P. Staging of non-small cell lung cancer by whole body flourine-18 deoxyglucose positron emission tomography Eur J Nucl Med 23 1996 204-206
20. 18FDG positron emission tomography in the staging of non-small cell lung cancer Eur Respir J 10 1997 2529-2534
21. Valk P. Pounds T. Hopkins D. et al. Staging non-small cell lung cancer by whole-body positron emission tomography imaging Ann Thorac Surg 60 1995 1573-1582
22. Bury T. Barreto A. Daenen F. Barthelemy N. Ghaye B. Rigo P. Flourine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with small cell lung cancer Eur J Nucl Med 25 1998 1244 1247
23. Marom E. Erasmus J. Patz E. Lung cancer and positron emisssion tomography with flourodeoxyglucose Lung Cancer 28 2000 187-202
24. Al-Sugair A. Coleman R. Relative diagnostic efficiency of F-18 FDG PET and bone scintigraphy for detection of osseous metastases in primary or secondary lung cancer J Nucl Med 40 1999 20P
25. Kao C.-H. Hsieh J. Tsai S.-C. Ho Y.-J. Yen R.-F. Comparison and discrepancy of F18-2-deoxyglucose postiron emission tompgraphy and Tc-99m MDP bone scan to detect bone metastases Anticancer Res 20 2000 2189-2192
26. Mundy G. Metastasis to bone: causes, consequences and therapeutic opportunities Nat Rev Cancer 2 2002 584-593
27. Cook G. Houston S. Rubens R. Maisey M. Fogelman I. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions J Clin Oncol 16 1998 3375-3379
28. Osada H. Kojima K. Tsukada H. Nakajima Y. Imamura K. Matsumoto J. Cost-effectiveness associated with the diagnosis and staging of non-small-cell lung cancer Jpn J Thorac Cardiovasc Surg 49 2001 1-10